• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect
Cardiovascular System
Cardiovascular System

Ramipril Oral Solution

Ramipril is an oral liquid medicine used to treat cardiovascular disease.

Ramipril Oral Suspension is indicated for the following:

– Treatment of hypertension.

– Cardiovascular prevention: reduction of cardiovascular morbidity and mortality in patients with:

• manifest atherothrombotic cardiovascular disease (history of coronary heart disease or stroke, or peripheral vascular disease) or

• diabetes with at least one cardiovascular risk factor.

– Treatment of renal disease:

• Incipient glomerular diabetic nephropathy as defined by the presence of microalbuminuria,

• Manifest glomerular diabetic nephropathy as defined by macroproteinuria in patients with at least one cardiovascular risk factor,

• Manifest glomerular non diabetic nephropathy as defined by macroproteinuria ≥ 3 g/day.

– Treatment of symptomatic heart failure.

– Secondary prevention after acute myocardial infarction: reduction of mortality from the acute phase of myocardial infarction in patients with clinical signs of heart failure when started > 48 hours following acute myocardial infarction.

Icon respresenting a network

Summary of Product Characteristics

Read this summary of product characteristics for further information about Ramipril Oral Suspension. Click below to navigate to the EMC.

More info
Icon respresenting a person

Patient Information Leaflet

Read this patient information leaflet about Ramipril Oral Suspension, what it’s used for and possible side effects. Click below to navigate to the EMC.

More info
Cardiovascular System

Ramipril Oral Solution

Rosemont Product Image Placeholder
Click here for Audio Version
Flavour Menthol
Storage Conditions Store in a refrigerator (2-8ºC).
Sucrose Free
Shelf Life (Closed Bottle/Open Bottle) 24 months / 1 month
PIP Code 116-8509
EAN Code 05016119000041
Sodium Levels Essentially sodium-free
Ethanol Concentration None

Downloads

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.

Rosemont Pharmaceuticals - World Map icon

Contact us

For further product information and pricing please use the form below and a member of the team will be in touch






    Please prove you are human by selecting the plane.

    Stay updated via our App

     

    A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.

    Rosemont app on a mobile device

    Cardiovascular System

    Rosemont Product Image Placeholder

    Ramipril Oral Solution